Pharmaceutical Technology ePT Weekly
Having trouble viewing this e-mail? CLICK HERE
PharmTech
April 18, 2019
PHARMTECH.COM CURRENT ISSUE SUBSCRIBE FORWARD
advertisement

In this issue:

PDA Strengthens its Global Presence

EMA Reviews Safety of Alemtuzumab

Patient-Centric Drug Development Comes of Age


Top Stories

Catalent to Acquire Paragon Bioservices for $1.2 Billion

Catalent’s acquisition of Paragon Bioservices will provide expertise in expanding gene therapy market.
/ read more /


Bristol-Myers Squibb Shareholders Approve Celgene Acquisition

Shareholders have approved the issuance of Bristol-Myers Squibb common stock for the pending $74-billion merger with Celgene.
/ read more /

advertisement

Subscribe

Subscribers can enjoy each full issue of Pharm Tech in print, or via Pharm Tech apps.

subscription offers
subscribe

advertisement

Industry News

Double, Double, Toil, and Trouble? The Brexit Cauldron May Bubble Away Until Halloween Under New Extension

Brexit has the potential to rumble on until Oct. 31, 2019 as the UK is granted a further six-month extension by European Union leaders.
/ read more /


Cross-Continent Partnership Aims to Advance Next-Generation Antimalarial Drug

EDCTP has granted EUR 10 million to a collaboration of African and European antimalarial drug researchers to support late-stage clinical trials of a novel antimalarial combination.
/ read more /


More Industry News
advertisement
advertisement

advertisement

Supplier News

Protagen Protein Services, BioAnalytix Merge into CRO

The companies will merge to offer a broader range of analytical data packages and regulatory support for biopharmaceuticals.
/ read more /


Hovione Technology Acquires Rights to New Blister-Based Inhaler

Hovione Technology has acquired global rights to a dry powder inhaler for pulmonary drug delivery, the Papillon DPI, invented by Dr. Klaus-Dieter Beller.
/ read more /


More Supplier News
advertisement
advertisement

advertisement

Bio/Pharma News

CPI Builds Open Innovation Facility for Continuous Wet Granulation

The UK’s Centre for Process Innovation is collaborating with GSK and AstraZeneca to establish a continuous wet granulation manufacturing facility for small-scale development of oral solid-dosage pharmaceuticals.
/ read more /


Novartis Gets FDA Nod for Brolucizumab Biologics License Application

Novartis has announced that FDA has accepted its biologics license application (BLA) for brolucizumab (RTH258) for the treatment of wet age-related macular degeneration (AMD).
/ read more /


More Bio/Pharma News

Regulatory News

EMA Reviews Safety of Alemtuzumab

EMA is evaluating the safety of Lemtrada (alemtuzumab) after new side effects were reported.
/ read more /


New York Facility Receives Warning Letter

FDA sent a warning letter to RIJ Pharmaceutical LLC after an inspection of the company’s Middletown, NY facility found CGMP violations.
/ read more /


More Regulatory News

advertisement

The pharma industry – defined.
Experience the long-standing expertise of CPhI with the convergence of pharma's most motivated buyers, experienced sellers, in addition to an array of networking opportunities at CPhI North America – happening April 30 – May 2, 2019 in Chicago, Illinois. Register now to walk our strategically zoned Expo Hall for free!
Click here to register for free.



FEATURED TOPICS

FORMULATION

Patient-Centric Drug Development Comes of Age

Easier access to information, targeting smaller patient populations, and increased regulatory focus on patient outcomes are driving patient centric drug development.
/ read more /

ANALYTICS

Cleaning Chromatography Resin Residues from Surfaces

Laboratory test methods evaluate cleaning agents and cleaning process design for removing resin residues from the surfaces of non-dedicated chromatography columns systems.
/ read more /

DRUG DELIVERY

Advanced Cell Penetrating Peptide Systems for Gene Therapy

Intracellular strategies offer an effective alternative approach to deliver a range of therapeutic proteins.
/ read more /

REGULATORY/GMP COMPLIANCE

PDA Strengthens its Global Presence

At INTERPHEX 2019, CEO Richard Johnson highlighted the importance of PDA’s new Asian business unit and outlined the organization’s plans. Data integrity guidance for manufacturing and quality systems will be published by the end of the year, as efforts move into big data and artificial intelligence.
/ read more /


UPCOMING WEBCASTs

Requirements for Fully-Integrated Service Offerings in a HPAPI and Cytotoxic Environment
Two Live Events: Tuesday, May 28, 2019, at 10am JST | 9pm EDT | 6pm PDT
Tuesday, May 28, 2019, at 5pm JST | 10am CEST
Register now


Geographic Advantage: Accelerating Clinical Supply in China and Global Trials
Thursday, May 9 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Register now


Beating the Clock: Case Studies in Expediting Biologic Development
Tuesday, May 7, 2019 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Register now


Sustainable Sourcing & Supply Chain Engagement in Pharma
Tuesday, May 7, 2019 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Register now


Approaches to Analyze and Understand 1–100 µm Particles/Aggregates in Biotherapeutics
Tuesday, April 23, 2019 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Register now


ON DEMAND WEBCASTS

Formulation Development for Scalability: Manufacturing Strategies for Bioavailability-Enhancing Technologies
On Demand
Learn More


Capsugel® Vcaps® Plus: The New Standard in HPMC Capsules
On Demand
Learn More


Ensuring Integrity of Drug Formulation from Development to QC
On Demand
Learn More



Events

2019 PDA Visual Inspection Forum

April 23–24, 2019

CPhI North America

April 30–May 2, 2019

SPE Minitec-PLUS PET/PLA Extrusion

May 1–2, 2019

more events

eBOOKS

Laboratory Best Practices 2018 eBook

The editors explore new tools for bio/pharma lab studies—such as robotics, augmented reality, and advanced instrumentation—as well as best practices for method development, multiple attribute monitoring, lab mixers, and raw material testing.


contribute | contact editors | CONTACT SALES | subscribe | advertise